Besides the newly acknowledged relevance of STK11 in lung cancer, this disease is characterized by other, well known genetic abnormalities, such as EGFR, BRAFv600E mutations, ALK, ROS, or RET rearrangements, as well as METexon14 mutations. Here, STK11 is linked to lung carcinoma.